Last date for submission of paper: 30-Mar-2020; Contact person: Clinical Biomarkers and World CDx EU Team; Uniting translational, clinical, regulatory and commercial functions, Clinical Biomarkers and World CDx Europe is your end-to-end meeting for translating exploratory signatures into clinically predictive biomarkers and overcoming key bottlenecks to driving adoption and access to game-changing diagnostic-enabled precision medicines.;Price:Free to attend as a Drug Developer: GBP 0.0;Speakers: Joanne Hackett, Chief Commercial Officer, Genomics England, Clare Balendran, Vice President, Translational Medicine, Novo Nordisk, Caoimhe Vallely-Gilroy, Healthcare Data Strategy, CEO Office Healthcare, Merck KGaA, Rowena Sharpe, Director, Precision Medicine Trials, University of Birmingham, Ellie Corigliano, Global Director Medical Affairs, Oncology, Thoracic and Pan Tumor Biomarkers and Diagnostics, Oncology Global Medical Affairs, Merck and Co., Berit Mikkelsen, Global Market Access Lead, Precision Medicine, LEO Pharma;Time: 8:00 am - 5:00 pm